用于筛选CAR-T治疗AML靶点的抗体组合物及其应用
本发明公开了一种用于筛选CAR‑T治疗AML靶点的抗体组合物及其应用,所述抗体组合物包括CD38抗体、CD371抗体、CD34抗体、CD117抗体、CD123抗体、CD33抗体、CD133抗体和CD45抗体。采用本发明的抗体组合物对待测样本进行检测,可以更准确地定位和识别恶性细胞群体,从而可以用于快速、准确地用于筛选CAR‑T治疗AML靶点,更早地发现疾病复发的迹象,提供更多关于疾病预后的信息,帮助医生和患者更好地理解疾病进程和可能的结果。
APPLICANTS
Browse source applicant names and unchanged name fields from imported patent records.
These are name-based results, not verified legal entities. Identical names may refer to different people or organizations; aliases and historical names are not merged.
This page matches the complete original name field. It may contain multiple applicants or another recorded party role. Name boundaries and legal identities have not been verified; punctuation is preserved, not split.
1 indexed patent records
Patent counts refer to distinct records held by this site, not an applicant’s complete portfolio. A joint name field is not a single company.
Verified corpus date coverage and last import time are not currently available. Publication dates on patent records are not import dates. Cached directory results may lag behind new imports.
Search the local original applicant field containing this full text. Results may include joint lists or longer names; this is not an exact identity search.
Search patents with this applicant condition